Vanguard Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $31.2M | Sell |
|
|||||
|
2025
Q2 | $22.9M | Buy |
|
|||||
|
2025
Q1 | $15.6M | Buy |
|
|||||
|
2024
Q4 | $30.6M | Sell |
|
|||||
|
2024
Q3 | $28.4M | Sell |
|
|||||
|
2024
Q2 | $25M | Buy |
|
|||||
|
2024
Q1 | $8.63M | Buy |
|
|||||
|
2023
Q4 | $7.14M | Buy |
|
|||||
|
2023
Q3 | $9M | Sell |
|
|||||
|
2023
Q2 | $31.9M | Sell |
|
|||||
|
2023
Q1 | $56.3M | Buy |
|
|||||
|
2022
Q4 | $63.8M | Buy |
|
|||||
|
2022
Q3 | $109M | Buy |
|
|||||
|
2022
Q2 | $158M | Sell |
|
|||||
|
2022
Q1 | $212M | Sell |
|
|||||
|
2021
Q4 | $233M | Buy |
|
|||||
|
2021
Q3 | $246M | Sell |
|
|||||
|
2021
Q2 | $312M | Buy |
|
|||||
|
2021
Q1 | $458M | Buy |
|
|||||
|
2020
Q4 | $429M | Buy |
|
|||||
|
2020
Q3 | $457M | Sell |
|
|||||
|
2020
Q2 | $376M | Buy |
|
|||||
|
2020
Q1 | $274M | Buy |
|
|||||
|
2019
Q4 | $252M | Buy |
|
|||||
|
2019
Q3 | $244M | Buy |
|
|||||
|
2019
Q2 | $223M | Sell |
|
|||||
|
2019
Q1 | $238M | Sell |
|
|||||
|
2018
Q4 | $286M | Buy |
|
|||||
|
2018
Q3 | $303M | Buy |
|
|||||
|
2018
Q2 | $218M | Buy |
|
|||||
|
2018
Q1 | $219M | Buy |
|
|||||
|
2017
Q4 | $167M | Sell |
|
|||||
|
2017
Q3 | $146M | Buy |
|
|||||
|
2017
Q2 | $120M | Sell |
|
|||||
|
2017
Q1 | $110M | Buy |
|
|||||
|
2016
Q4 | $116M | Sell |
|
|||||
|
2016
Q3 | $116M | Buy |
|
|||||
|
2016
Q2 | $102M | Buy |
|
|||||
|
2016
Q1 | $116M | Buy |
|
|||||
|
2015
Q4 | $116M | Buy |
|
|||||
|
2015
Q3 | $66.4M | Buy |
|
|||||
|
2015
Q2 | $73.3M | Buy |
|
|||||
|
2015
Q1 | $61.8M | Buy |
|
|||||
|
2014
Q4 | $56M | Buy |
|
|||||
|
2014
Q3 | $43.5M | Buy |
|
|||||
|
2014
Q2 | $45.3M | Buy |
|
|||||
|
2014
Q1 | $50M | Buy |
|
|||||
|
2013
Q4 | $42.4M | Buy |
|
|||||
|
2013
Q3 | $33.4M | Buy |
|
|||||
|
2013
Q2 | $24.5M | Buy |
|